Early detection of pancreatic cancer

Victoria M. Kim, Nita Ahuja

Research output: Contribution to journalArticle

Abstract

Pancreatic adenocarcinoma is a low-incident but highly mortal disease. It accounts for only 3% of estimated new cancer cases each year but is currently the fourth common cause of cancer mortality. By 2030, it is expected to be the 2nd leading cause of cancer death. There is a clear need to diagnose and classify pancreatic cancer at earlier stages in order to give patients the best chance at a definitive cure through surgery. Three precursor lesions that distinctly lead to pancreatic adenocarcinoma have been identified, and we have increasing understanding the non-genetic and genetic risk factors for the disease. With increased understanding about the risk factors, the familial patters, and associated accumulation of genetic mutations involved in pancreatic cancer, we know that there are mutations that occur early in the development of pancreatic cancer and that improved genetic risk-based strategies in screening for pancreatic cancer may be possible and successful at saving or prolonging lives. The remaining challenge is that current standards for diagnosing pancreatic cancer remain too invasive and too costly for widespread screening for pancreatic cancer. Furthermore, the promises of noninvasive methods of detection such as blood, saliva, and stool remain underdeveloped or lack robust testing. However, significant progress has been made, and we are drawing closer to a strategy for the screening and early detection of pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)321-331
Number of pages11
JournalChinese Journal of Cancer Research
Volume27
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Pancreatic Neoplasms
Early Detection of Cancer
Adenocarcinoma
Neoplasms
Saliva
Cause of Death
Mutation
Mortality

Keywords

  • Early detection
  • Familial pancreatic cancer
  • Pancreatic cancer
  • Screening

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Early detection of pancreatic cancer. / Kim, Victoria M.; Ahuja, Nita.

In: Chinese Journal of Cancer Research, Vol. 27, No. 4, 2015, p. 321-331.

Research output: Contribution to journalArticle

Kim, Victoria M. ; Ahuja, Nita. / Early detection of pancreatic cancer. In: Chinese Journal of Cancer Research. 2015 ; Vol. 27, No. 4. pp. 321-331.
@article{ab487cdef1644a4695db790508d9ebb1,
title = "Early detection of pancreatic cancer",
abstract = "Pancreatic adenocarcinoma is a low-incident but highly mortal disease. It accounts for only 3{\%} of estimated new cancer cases each year but is currently the fourth common cause of cancer mortality. By 2030, it is expected to be the 2nd leading cause of cancer death. There is a clear need to diagnose and classify pancreatic cancer at earlier stages in order to give patients the best chance at a definitive cure through surgery. Three precursor lesions that distinctly lead to pancreatic adenocarcinoma have been identified, and we have increasing understanding the non-genetic and genetic risk factors for the disease. With increased understanding about the risk factors, the familial patters, and associated accumulation of genetic mutations involved in pancreatic cancer, we know that there are mutations that occur early in the development of pancreatic cancer and that improved genetic risk-based strategies in screening for pancreatic cancer may be possible and successful at saving or prolonging lives. The remaining challenge is that current standards for diagnosing pancreatic cancer remain too invasive and too costly for widespread screening for pancreatic cancer. Furthermore, the promises of noninvasive methods of detection such as blood, saliva, and stool remain underdeveloped or lack robust testing. However, significant progress has been made, and we are drawing closer to a strategy for the screening and early detection of pancreatic cancer.",
keywords = "Early detection, Familial pancreatic cancer, Pancreatic cancer, Screening",
author = "Kim, {Victoria M.} and Nita Ahuja",
year = "2015",
doi = "10.3978/j.issn.1000-9604.2015.07.03",
language = "English (US)",
volume = "27",
pages = "321--331",
journal = "Chinese Journal of Cancer Research",
issn = "1000-9604",
publisher = "Beijing Institute for Cancer Research",
number = "4",

}

TY - JOUR

T1 - Early detection of pancreatic cancer

AU - Kim, Victoria M.

AU - Ahuja, Nita

PY - 2015

Y1 - 2015

N2 - Pancreatic adenocarcinoma is a low-incident but highly mortal disease. It accounts for only 3% of estimated new cancer cases each year but is currently the fourth common cause of cancer mortality. By 2030, it is expected to be the 2nd leading cause of cancer death. There is a clear need to diagnose and classify pancreatic cancer at earlier stages in order to give patients the best chance at a definitive cure through surgery. Three precursor lesions that distinctly lead to pancreatic adenocarcinoma have been identified, and we have increasing understanding the non-genetic and genetic risk factors for the disease. With increased understanding about the risk factors, the familial patters, and associated accumulation of genetic mutations involved in pancreatic cancer, we know that there are mutations that occur early in the development of pancreatic cancer and that improved genetic risk-based strategies in screening for pancreatic cancer may be possible and successful at saving or prolonging lives. The remaining challenge is that current standards for diagnosing pancreatic cancer remain too invasive and too costly for widespread screening for pancreatic cancer. Furthermore, the promises of noninvasive methods of detection such as blood, saliva, and stool remain underdeveloped or lack robust testing. However, significant progress has been made, and we are drawing closer to a strategy for the screening and early detection of pancreatic cancer.

AB - Pancreatic adenocarcinoma is a low-incident but highly mortal disease. It accounts for only 3% of estimated new cancer cases each year but is currently the fourth common cause of cancer mortality. By 2030, it is expected to be the 2nd leading cause of cancer death. There is a clear need to diagnose and classify pancreatic cancer at earlier stages in order to give patients the best chance at a definitive cure through surgery. Three precursor lesions that distinctly lead to pancreatic adenocarcinoma have been identified, and we have increasing understanding the non-genetic and genetic risk factors for the disease. With increased understanding about the risk factors, the familial patters, and associated accumulation of genetic mutations involved in pancreatic cancer, we know that there are mutations that occur early in the development of pancreatic cancer and that improved genetic risk-based strategies in screening for pancreatic cancer may be possible and successful at saving or prolonging lives. The remaining challenge is that current standards for diagnosing pancreatic cancer remain too invasive and too costly for widespread screening for pancreatic cancer. Furthermore, the promises of noninvasive methods of detection such as blood, saliva, and stool remain underdeveloped or lack robust testing. However, significant progress has been made, and we are drawing closer to a strategy for the screening and early detection of pancreatic cancer.

KW - Early detection

KW - Familial pancreatic cancer

KW - Pancreatic cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84940549705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940549705&partnerID=8YFLogxK

U2 - 10.3978/j.issn.1000-9604.2015.07.03

DO - 10.3978/j.issn.1000-9604.2015.07.03

M3 - Article

C2 - 26361402

AN - SCOPUS:84940549705

VL - 27

SP - 321

EP - 331

JO - Chinese Journal of Cancer Research

JF - Chinese Journal of Cancer Research

SN - 1000-9604

IS - 4

ER -